Satellos Bioscience Inc (MSLE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,697 | 9,804 | 19,304 | 38,217 | 32,712 |
| Marketable Securities | 51,214 | 17,906 | 15,310 | N/A | 8,478 |
| Receivables | 726 | 370 | 205 | 186 | 338 |
| TOTAL | $75,218 | $31,884 | $37,497 | $41,112 | $44,365 |
| Non-Current Assets | |||||
| PPE Net | 8 | 5 | 6 | 5 | 3 |
| TOTAL | $8 | $5 | $6 | $5 | $3 |
| Total Assets | $75,226 | $31,889 | $37,503 | $41,117 | $44,368 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,563 | 4,105 | 3,503 | 2,770 | 2,699 |
| TOTAL | $4,563 | $4,105 | $3,503 | $2,770 | $2,699 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,563 | $4,105 | $3,503 | $2,770 | $2,699 |
| Shareholders' Equity | |||||
| Common Shares | 133,884 | 85,828 | 85,546 | 82,512 | 78,134 |
| Retained earnings | -91,738 | -81,970 | -74,667 | -68,846 | -63,238 |
| Other shareholders' equity | 17,624 | 13,760 | 13,805 | 15,906 | 18,426 |
| TOTAL | $70,663 | $27,784 | $34,000 | $38,347 | $41,669 |
| Total Liabilities And Equity | $75,226 | $31,889 | $37,503 | $41,117 | $44,368 |